Vitamin B12 (Cobalamin): Methyl vs Cyano, Dosage & Who Actually Needs It

What is vitamin B12?

Vitamin B12 is a cobalt-containing corrinoid — the only vitamin that contains a metal atom and the only one synthesized exclusively by bacteria and archaea. Animals (and humans) obtain it second-hand by eating animal tissues that have accumulated bacterial B12, or via fortified foods and supplements.

What makes B12 unusual is its absorption pathway, which is more complex than any other vitamin. To absorb dietary B12 you need:

• Gastric acid and pepsin in the stomach — to release B12 from food protein
• Intrinsic factor — a glycoprotein secreted by gastric parietal cells that binds free B12
• An intact terminal ileum — where intrinsic-factor-bound B12 is taken up by cubilin receptors
• Transcobalamin II — the plasma carrier that delivers B12 to cells

This explains a critical clinical fact: most adult B12 deficiencies are not dietary — they are absorption failures. Dietary deficiency takes years to develop because the liver stores 2–5 mg (a 3–5 year supply at typical use rates).

According to the NIH Office of Dietary Supplements, B12 acts as a coenzyme in two reactions: methionine synthase (regenerating methionine from homocysteine, intersecting with folate metabolism) and L-methylmalonyl-CoA mutase (a mitochondrial enzyme in branched-chain amino acid and odd-chain fatty acid catabolism).

Evidence-based benefits of vitamin B12 supplementation

1. Megaloblastic anemia repletion

This is the gold-standard indication. In documented B12-deficiency anemia, supplementation (oral high-dose or intramuscular) reliably restores hematologic parameters within 1–2 months. If treatment begins before nerve damage develops, recovery is essentially complete. The challenge is that deficiency is often diagnosed late.

2. Cognitive function

Observational studies have repeatedly linked low or low-normal B12 with cognitive decline and accelerated brain atrophy. However, randomized trials of B12 (alone or combined with folate and B6) in non-deficient older adults — including FACT and VITACOG — have been largely negative for hard cognitive outcomes. Translation: correct deficiency, but don't expect a dementia-prevention effect from supplementing replete people.

3. Mood and depression adjunct

The signal is modest and concentrated in subgroups with deficiency or borderline-low B12 — patients with confirmed low B12 who are also on antidepressants tend to have better response rates. In replete patients, B12 has not shown a reproducible antidepressant effect.

4. Homocysteine reduction

B12, folate, and B6 reliably lower plasma homocysteine. The catch: large hard-outcome trials (HOPE-2, NORVIT, VISP, SEARCH) showed that lowering homocysteine pharmacologically does not reduce cardiovascular events. The biomarker improves; the disease doesn't.

5. Neuropathy and pernicious-anemia neurology

This is a real, established neurological indication. B12 deficiency causes subacute combined degeneration of the dorsal and lateral spinal columns (myelopathy) plus peripheral neuropathy. Early repletion can prevent permanent damage; advanced damage may be only partially reversible. This is the strongest reason not to delay treatment when deficiency is suspected.

Symptoms of vitamin B12 deficiency

B12 deficiency presents along two overlapping axes — hematologic and neurologic — and they don't always appear together:

• Megaloblastic (macrocytic) anemia — fatigue, pallor, dyspnea on exertion, elevated MCV
• Glossitis — a smooth, beefy-red, painful tongue
• Peripheral neuropathy — symmetrical paresthesias ("pins and needles"), often starting in the feet
• Gait ataxia and proprioception loss — from subacute combined degeneration of the spinal cord
• Cognitive symptoms — memory issues, difficulty concentrating, "brain fog"
• Mood changes — depression, irritability

Critical clinical point: neurological symptoms can occur without anemia if folate intake is adequate. High-dose folate (or folic acid food fortification) "masks" the hematological signal of B12 deficiency while the neurology silently progresses. This is why B12 status should be checked alongside folate, never inferred from a normal CBC.

Who is at risk?

• Vegans and long-term vegetarians — deficiency develops over years thanks to liver stores, but is essentially universal without supplementation or fortified foods
• Adults 60+ — roughly 6% are frankly deficient and another 10–20% are marginal, primarily from food-bound cobalamin malabsorption (reduced gastric acid)
• Long-term metformin users — dose- and duration-dependent reduction in B12 absorption
• PPI and H2-blocker users — reduced gastric acid impairs release of food-bound B12; clinically relevant after years of use
• Pernicious anemia — autoimmune destruction of parietal cells / antibodies against intrinsic factor
• Post-bariatric surgery — particularly Roux-en-Y gastric bypass; lifelong supplementation is standard
• Crohn's disease, ileal resection, or short-bowel syndrome — disrupted ileal absorption
• Fish tapeworm (Diphyllobothrium latum) infection — rare but classic

Diagnosis combines serum B12 with methylmalonic acid (MMA) and homocysteine — both rise in functional deficiency even when serum B12 looks borderline. For an in-depth check, see our complete deficiency symptom guide.

The supplement forms of vitamin B12, compared

B12 supplements come in four main chemical forms plus several delivery routes. The form on the label matters less than most marketing suggests — but it isn't zero.

Methylcobalamin vs cyanocobalamin: which form should you choose?

This is the most common B12 question on the internet. The honest answer: for the overwhelming majority of healthy adults, cyanocobalamin is perfectly fine — it is cheap, extremely stable, and the body removes the cyanide group (a trivial amount, far below any toxicity threshold) and converts it to the active coenzyme forms intracellularly. Methylcobalamin is the active coenzyme delivered ready-to-use, has a slight retention advantage in some studies, and is a sensible default for sublingual products. The clinical difference for routine supplementation is minor.

For a deeper comparison, see Methylcobalamin vs Cyanocobalamin.

How much vitamin B12 should you take?

The Recommended Dietary Allowance (RDA) for adults is 2.4 µg/day. This is trivially met by any omnivorous diet. Supplement doses are far higher because oral absorption efficiency drops sharply at higher doses (intrinsic factor saturates at about 1.5–2 µg per meal) — and because passive absorption picks up a small but useful fraction of any megadose.

• RDA (adults): 2.4 µg/day · Pregnancy: 2.6 µg · Lactation: 2.8 µg
• Maintenance for vegans: 250–1,000 µg/day, or 2,000 µg once weekly
• Treatment of deficiency (oral): 1,000–2,000 µg/day. At this dose, ~1% absorbs passively, bypassing intrinsic factor entirely
• Pernicious anemia (traditional): IM hydroxocobalamin or cyanocobalamin 1,000 µg weekly × 4–8 weeks, then monthly. Modern trials show high-dose oral 1,000–2,000 µg/day is non-inferior for most patients

Tolerable Upper Intake Level: none has been set. B12 has no documented toxicity at any oral dose tested.

Side effects and safety

B12 has an excellent safety profile — among the safest of all supplemented vitamins. There is no Tolerable Upper Intake Level. Adverse effects worth knowing about:

• Acneiform / rosacea-like eruption — rare; reported with high-dose cyanocobalamin (and to a lesser extent the other forms)
• Hypokalemia — possible during the first days of repletion in severe megaloblastic anemia, as the surge of new red-cell production pulls potassium intracellularly. Monitor in inpatient settings
• Allergic reaction to cobalt — rare; can manifest as hypersensitivity to injection
• Elevated serum B12 readings — high serum B12 in people not supplementing has been associated with underlying disease (liver disease, certain malignancies). The lab number itself is not the problem

Drug interactions to know about

• Metformin — long-term use (especially >4 years and at higher doses) reduces B12 absorption. The American Diabetes Association recommends periodic B12 testing in patients on metformin
• Proton pump inhibitors and H2 blockers — reduced gastric acid impairs release of food-bound B12; clinically relevant after years of continuous use
• Colchicine, neomycin, aminosalicylic acid — all reduce ileal B12 absorption with chronic use
• Chloramphenicol — antagonizes the hematologic response to B12 therapy
• Nitrous oxide (N₂O) — anesthetic and recreational ("whippets") use irreversibly oxidizes the cobalt atom in B12. A single anesthetic exposure can precipitate severe deficiency in a marginal patient; chronic recreational use causes profound neurological deficiency

Check our free interaction checker for a complete list.

Frequently asked questions

Related articles